Role of experience in Myectomy for hypertrophic cardiomyopathy: With very high procedural volume, Myectomy remains low-risk even with concomitant procedure need

Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy, affecting an estimated 1/200 to 1/500 people. [1] Dynamic left ventricular outflow tract (LVOT) is present in the majority of patients with HCM, either at rest or with provocation. Dynamic LVOT obstruction is a major cause of symptoms, is associated with worse outcomes, and remains the primary therapeutic target in the treatment of obstructive HCM. [2] In patients with medically refractory symptoms related to dynamic LVOT obstruction, advanced therapies, including septal reduction therapy (SRT), are recommended.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research